Cell surface-directed interaction of anthracyclines leads to cytotoxicity and nuclear factor κB activation but not apoptosis signaling

Cancer Research

Volumn 61, Issue 6, 2001, Pages 2558-2561

  Maestre, Nicolas ^a   Tritton, Thomas R ^b   Laurent, Guy ^a,c   Jaffrézou, Jean Pierre ^a  

^a INSTITUT CLAUDIUS REGAUD   (France)

^b HAVERFORD COLLEGE   (United States)

^c CHU PURPAN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AGAROSE; ANTHRACYCLINE ANTIBIOTIC AGENT; DAUNORUBICIN; DOXORUBICIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; SPHINGOMYELIN PHOSPHODIESTERASE;

APOPTOSIS; ARTICLE; CELL DEATH; CELL SURVIVAL; CONTROLLED STUDY; CYTOTOXICITY; DRUG DNA INTERACTION; ENZYME ACTIVATION; GENE INDUCTION; GENETIC DAMAGE; HUMAN; HUMAN CELL; INTERNALIZATION; MOLECULAR INTERACTION; MYELOID LEUKEMIA; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANTIBIOTICS, ANTINEOPLASTIC; APOPTOSIS; CELL MEMBRANE; CERAMIDES; DAUNORUBICIN; DNA FRAGMENTATION; DOXORUBICIN; HUMANS; NF-KAPPA B; SIGNAL TRANSDUCTION; U937 CELLS;

EID: 0035866805     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Clinical pharmacology of cancer chemotherapy
2. Cell surface actions of Adriamycin
3. Relationship of Adriamycin concentrations to the DNA lesions induced in hypoxic and euoxic L1210 cells
4. Qualitative and quantitative aspects of intercalator-induced DNA strand breaks
5. Cytotoxicity and DNA strand breaks by 5-iminodaunorubicin in mouse leukemia L1210 cells: Comparison with Adriamycin and 4′-(9-acridinylamino)methanesulfon-m-aniside
6. Daunorubicin-induced apoptosis; triggering of ceramide generation through sphingomyelin hydrolysis
7. The anticancer agent Adriamycin can be actively cytotoxic without entering cells
8. Daunorubicin-induced internucleosomal DNA fragmentation in acute myeloid cell lines
9. Evidence against involvement of the acid lysosomal sphingomyelinase in the tumor-necrosis-factor- and interleukin-1-induced sphingomyelin cycle and cell proliferation in human fibroblasts
10. Measurement of proteins using bicinchoninic acid
11. A simple method for the isolation and purification of total lipids from animal tissues
12. Functional dichotomy of neutral and acidic sphingomyelinases in tumor necrosis factor signaling
13. Topoisomerase poisons activate the transcription factor NF-κB in ACH-2 and CEM cells
14. TNF- and cancer therapy-induced apoptosis: Potentiation by inhibition of NF-κ B
15. Daunorubicin activates NFκB and induces κB-dependent gene expression in HL-60 promyelocytic and Jurkat T lymphoma cells
16. Activation of NF-κB by antineoplastic agents
17. Nuclear factor-κB-dependent regulation of p53 gene expression induced by daunomycin genotoxic drug
18. Stable inhibition of nuclear factor κB in cancer cells does not increase sensitivity to cytotoxic drugs
19. NF-κB activation by ultraviolet light not dependent on a nuclear signal
20. TNF activates NF-κB by phosphatidylcholine-specific phospholipase C-induced "acidic" sphingomyelin breakdown
21. Serine-protease inhibitors block neutral sphingomyelinase activation, ceramide generation, and apoptosis triggered by daunorubicin
22. Dissociation of endogenous cellular ceramide from NF-κB activation
23. Inhibition of ceramide pathway does not affect ability of TNF-α to activate nuclear factor-κB
24. Inhibition of NF-κB/Rel induces apoptosis of murine B cells
25. Constitutive nuclear factor-κB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells
26. An essential role for NF-κB in human CD34+ bone marrow cell survival
27. An essential role for NF-κB in preventing TNF-α-induced cell death
28. Suppression of TNF-α-induced apoptosis by NF-κB
29. Immunosuppression by glucocorticoids: Inhibition of NF-κB activity through induction of IκB synthesis
30. Role of transcriptional activation of IκBα in mediation of immunosuppression by glucocorticoids